Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Udelson

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Circulation. Heart Failure|September 9, 2020
Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic ShockKatherine L Thayer, Elric Zweck, Mohyee Ayouty, et al.
The American Journal of Cardiology|June 1, 2015
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic CardiomyopathyRaymond H Chan, Barry J Maron, Iacopo Olivotto, et al.
European Journal of Heart Failure|October 30, 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trialYogesh N V Reddy, Javed Butler, Kevin J Anstrom, et al.
European Journal of Heart Failure|February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trialClara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
European Journal of Heart Failure|September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trialRobert J Mentz, Javed Butler, Ciaran J McMullan, et al.
Journal of the American College of Cardiology|September 2, 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTORFaiez Zannad, Yogesh N V Reddy, Irina Barash, et al.
European Heart Journal|August 30, 2025
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trialJaved Butler, Francesco Fioretti, Ciaran J McMullan, et al.
Lancet (London, England)|September 2, 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialJaved Butler, Ciaran J McMullan, Kevin J Anstrom, et al.
Lancet (London, England)|September 2, 2025
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trialsFaiez Zannad, Christopher M O'Connor, Javed Butler, et al.
Journal of the American College of Cardiology|April 24, 2026
Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction Without Shock: The ST-Segment Elevation Myocardial Infarction Door to Unload Randomized Controlled TrialNavin K Kapur, Norman Mangner, Nima Aghili, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Circulation. Heart Failure|September 9, 2020
Invasive Hemodynamic Assessment and Classification of In-Hospital Mortality Risk Among Patients With Cardiogenic ShockKatherine L Thayer, Elric Zweck, Mohyee Ayouty, et al.
The American Journal of Cardiology|June 1, 2015
Significance of Late Gadolinium Enhancement at Right Ventricular Attachment to Ventricular Septum in Patients With Hypertrophic CardiomyopathyRaymond H Chan, Barry J Maron, Iacopo Olivotto, et al.
European Journal of Heart Failure|October 30, 2024
Vericiguat Global Study in Participants with Chronic Heart Failure: Design of the VICTOR trialYogesh N V Reddy, Javed Butler, Kevin J Anstrom, et al.
European Journal of Heart Failure|February 16, 2025
Baseline characteristics of contemporary trial participants with heart failure and reduced ejection fraction: The VICTOR trialClara I Saldarriaga, Faiez Zannad, Ciaran J McMullan, et al.
European Journal of Heart Failure|September 29, 2025
Blood pressure, safety and clinical efficacy of vericiguat in chronic heart failure with reduced ejection fraction: Insights from the VICTOR trialRobert J Mentz, Javed Butler, Ciaran J McMullan, et al.
Journal of the American College of Cardiology|September 2, 2025
Effect of Vericiguat on Worsening Heart Failure in Compensated Outpatients with HFrEF: Insights from VICTORFaiez Zannad, Yogesh N V Reddy, Irina Barash, et al.
European Heart Journal|August 30, 2025
Vericiguat and mortality in heart failure and reduced ejection fraction: the VICTOR trialJaved Butler, Francesco Fioretti, Ciaran J McMullan, et al.
Lancet (London, England)|September 2, 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trialJaved Butler, Ciaran J McMullan, Kevin J Anstrom, et al.
Lancet (London, England)|September 2, 2025
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trialsFaiez Zannad, Christopher M O'Connor, Javed Butler, et al.
Journal of the American College of Cardiology|April 24, 2026
Left Ventricular Unloading in Anterior ST-Segment Elevation Myocardial Infarction Without Shock: The ST-Segment Elevation Myocardial Infarction Door to Unload Randomized Controlled TrialNavin K Kapur, Norman Mangner, Nima Aghili, et al.
Pageof 3